Additional reporting: Paul Brackley AstraZeneca is planning a new office building with an auditorium and conference centre on Cambridge Biomedical Campus.

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to ...

Women who kill are not characterized by psychopathy. Instead, they act primarily because they feel provoked and threatened. At the same time, there is a certain degree of planning among the group of ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid US leader Donald Trump's threats to impose tariffs on the sector.

AstraZeneca announces massive investment in the US ahead of Trump tariff deadline Cambridge, UK - British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the US amid a ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington. The United States is a key market ...

Human norovirus (HuNoV) causes winter vomiting disease and is the most common reason of gastrointestinal infection outbreaks across different environments and all age groups around the world. The ...

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration - though much of what it is ...

AstraZeneca pledges $50 bln investment in US as pharma tariffs loom Author Ambar Warrick Stock Markets Published 07/21/2025, 08:56 PM ...

AstraZeneca to invest $50 bln in US as pharma tariffs loom AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030.

AstraZeneca CEO Pascal Soriot discusses the company's $50 billion investment in the U.S. economy. Barack Obama responds to Donald Trump's Russia "treason" threats Ozzy Osbourne, heavy metal music ...

Drug maker AstraZeneca has announced plans to invest 50 billion dollars (£37 billion) in the US over the next five years amid the looming threat of President Donald Trump’s trade tariffs.